ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VERV Verve Therapeutics Inc

6.42
0.00 (0.00%)
Pre Market
Last Updated: 04:00:57
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000929k1.01M1.4M2.09M3.12M
Operating Income -32.54M-31.93M-42.19M-43.86M-47.71M-58.26M-58.58M-52.33M
Pre Tax Income -31.34M-30.17M-40.95M-45.19M-41.03M-51.98M-53.81M-45.69M
Net Income -31.34M-30.17M-40.95M-45.19M-41.09M-51.98M-53.98M-45.76M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -31.4M-30.25M-41.25M-44.55M-46.22M-57.52M-59.25M-51.53M
EBITDA -32.07M-31.41M-41.54M-43.14M-46.79M-57.13M-57.25M-50.86M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0001.94M11.76M
Operating Income -13.64M-40.63M-87.07M-165.69M-223.12M
Pre Tax Income -19.3M-45.7M-120.31M-157.33M-199.79M
Net Income -19.3M-45.7M-120.31M-157.39M-200.07M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -10.408-17.674-2.48-2.55-3.138
EBIT -19.58M-45.87M-120.46M-164.2M-222.96M
EBITDA -13.54M-39.3M-85.53M-162.88M-217.67M

Your Recent History

Delayed Upgrade Clock